DNASE2 antibodies are immunological reagents designed specifically for the detection and study of deoxyribonuclease 2 (DNASE2), a lysosomal enzyme essential for DNA degradation. These antibodies bind to specific epitopes on the DNASE2 protein, enabling its visualization and quantification across various experimental platforms . Available from multiple commercial suppliers, DNASE2 antibodies have become indispensable tools in molecular biology, immunology, and clinical research fields .
The development of high-quality DNASE2 antibodies has significantly advanced our understanding of this enzyme's structure, localization, and function. Most commonly, these antibodies are generated by immunizing host animals (typically rabbits) with peptide sequences derived from the human DNASE2 protein, often targeting regions near the carboxy terminus . Both polyclonal and monoclonal variants are commercially available, offering researchers flexibility in experimental design and application.
DNASE2 antibodies have confirmed that the protein is predominantly localized within lysosomes, consistent with its function in degrading DNA under acidic conditions . Subcellular fractionation studies coupled with immunoblotting have definitively established the lysosomal compartmentalization of both the 23 kDa and 30 kDa processed forms of DNASE2 . This localization is critical for the enzyme's role in degrading DNA from phagocytosed apoptotic cells and expelled nuclei from erythroid precursors.
Immunohistochemical studies using DNASE2 antibodies have demonstrated that the protein is primarily expressed in monocytes and macrophages, consistent with its role in phagocytic DNA clearance . The tissue-specific expression pattern of DNASE2 aligns with its biological function in clearing cellular debris and processing nucleic acids from dying cells.
DNASE2, the target antigen of DNASE2 antibodies, performs critical functions in cellular homeostasis and immune regulation. Understanding these functions provides context for the applications of DNASE2 antibodies in research and diagnostics.
The primary function of DNASE2 is to hydrolyze DNA under acidic conditions, with a preference for double-stranded DNA . This activity is crucial for the clearance of nucleic acids generated through apoptosis, preventing potential autoimmune responses to self-DNA . DNASE2 antibodies have been instrumental in elucidating this function through localization and activity studies.
DNASE2 plays an essential role in erythrocyte development. During the maturation of red blood cells, nuclei are expelled and must be properly degraded by macrophages expressing DNASE2 . Studies using DNASE2 antibodies have demonstrated that the enzyme is necessary for definitive erythropoiesis in fetal liver and bone marrow, where it degrades nuclear DNA expelled from erythroid precursor cells .
Recent research has uncovered a critical role for DNASE2 in regulating innate immune responses. Studies have shown that DNASE2 is required for proper TLR9 (Toll-like receptor 9) responses to CpG-A, a type of synthetic DNA that mimics bacterial DNA . Specifically, DNASE2 cleaves CpG-A oligonucleotides from 20-mer to 11-12-mer fragments, and these processed fragments are necessary for activating certain immune cells . This finding highlights the enzyme's role in facilitating appropriate immune responses to nucleic acids.
Most commercially available DNASE2 antibodies are polyclonal, typically raised in rabbits against specific peptide sequences of human DNASE2 . These antibodies are commonly generated using immunogens consisting of 14-amino acid peptides near the carboxy terminus of human DNASE2 . The polyclonal nature provides broad epitope recognition but may introduce batch-to-batch variability.
DNASE2 antibodies are available in both conjugated and non-conjugated forms, expanding their utility across different experimental platforms . Conjugated forms may include fluorescent tags for direct visualization in immunofluorescence or flow cytometry applications.
DNASE2 antibodies have proven valuable across multiple experimental techniques, enabling researchers to investigate the enzyme's expression, localization, and function.
DNASE2 antibodies are extensively used in Western blot applications to detect and quantify DNASE2 protein in various samples . Typically, these antibodies can detect the DNASE2 protein at concentrations as low as 0.5 μg/mL . The antibodies can identify the approximately 40 kDa pro-enzyme form of DNASE2, as well as the processed 30 kDa and 23 kDa forms when appropriate sample preparation techniques are employed .
For tissue localization studies, DNASE2 antibodies can be applied in immunohistochemistry starting at concentrations of 5 μg/mL . Similarly, the antibodies are effective in immunofluorescence applications at the same starting concentration . These techniques have been crucial for determining the cellular and subcellular distribution of DNASE2 in various tissues and confirming its predominant lysosomal localization .
DNASE2 antibodies are compatible with enzyme-linked immunosorbent assays (ELISA) and other immunoassay formats, enabling quantitative detection of the protein in complex biological samples . These applications are particularly useful for high-throughput screening and protein quantification studies.
Beyond standard detection techniques, DNASE2 antibodies have been instrumental in more complex research applications, including:
Studying the proteolytic processing of DNASE2 using immunoprecipitation
Investigating DNASE2 deficiency and its role in autoinflammatory conditions
Examining the interaction between DNASE2 and nucleic acid sensing pathways
Analyzing the role of DNASE2 in erythropoiesis and DNA clearance
Research utilizing DNASE2 antibodies has yielded significant insights into the enzyme's role in health and disease.
Studies employing DNASE2 antibodies have revealed that DNASE2 plays a crucial role in DNA sensing pathways, particularly in the context of TLR9 activation. Research has demonstrated that DNASE2 is required for TLR9 responses to CpG-A, a type of immunostimulatory DNA, but not for responses to CpG-B . This selective requirement highlights the enzyme's role in processing specific types of DNA for immune recognition.
Importantly, enzymatically inactive DNASE2 mutants cannot rescue CpG-A responses in DNASE2-deficient dendritic cells, indicating that the enzyme's catalytic activity is essential for this function . These findings suggest that DNASE2-mediated DNA cleavage generates specific fragments that are optimal for TLR9 activation, establishing a mechanistic link between DNA degradation and immune signaling.
Immunological studies using anti-DNASE2 antibodies have uncovered important details about the enzyme's biogenesis and processing. Research has shown that DNASE2 undergoes proteolytic processing when overexpressed in cell lines, and this processing can be suppressed by protease inhibitors . Further investigation revealed that DNASE2 processing is dependent on cathepsin L, a lysosomal protease .
These findings have significant implications for understanding how DNASE2 activity is regulated within cells and how its function might be modulated in disease states. The ability to detect both the pro-enzyme and processed forms of DNASE2 using specific antibodies has been crucial for these discoveries.
DNASE2 antibodies have been instrumental in elucidating the pathological consequences of DNASE2 deficiency, particularly in the context of autoinflammatory diseases.
The DNASE2 gene has been associated with Autoinflammatory-pancytopenia syndrome (AIPCS), a rare genetic disorder . Research utilizing DNASE2 antibodies has helped characterize the molecular basis of this condition, which involves biallelic loss-of-function mutations in the DNASE2 gene .
Studies have revealed that patients with DNASE2 deficiency exhibit a spectrum of clinical features, including resolving neonatal anemia, membranoproliferative glomerulonephritis, liver fibrosis, deforming arthropathy, and increased anti-DNA antibodies . These manifestations reflect the consequences of impaired DNA clearance and the resulting autoinflammatory response.
Perhaps the most significant finding regarding DNASE2 deficiency is its classification as a type I interferonopathy . Research has demonstrated that patients with DNASE2 mutations show increased interferon alpha protein levels, enhanced interferon signaling, and constitutive upregulation of phosphorylated STAT1 and STAT3 in lymphocytes and monocytes .
This interferon signature results from the chronic activation of cytosolic DNA sensing pathways, particularly the cGAS-STING pathway, due to the accumulation of undigested DNA . DNASE2 antibodies have been crucial for confirming the loss of DNASE2 protein expression or function in patient samples, establishing the causal relationship between DNASE2 deficiency and type I interferon activation.
Studies in animal models have further illuminated the consequences of DNASE2 deficiency. In Drosophila, knockdown of DNASE2 activity resulted in a dramatic reduction of DNase II activity and a significant decrease in hemocyte numbers . Furthermore, infection of DNASE2-RNAi flies with bacteria resulted in severely reduced viability, confirming the importance of DNASE2 in maintaining proper immune function .
These findings from experimental models complement the clinical observations in human patients, underscoring the evolutionary conservation of DNASE2's role in DNA clearance and immune homeostasis.
DNASE2 (deoxyribonuclease II, lysosomal) is a lysosomal endonuclease that hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. It plays crucial roles in:
Degradation of DNA from apoptotic nuclei in phagocytes
Clearance of DNA during erythropoiesis in fetal liver and bone marrow
Maintenance of skin cell homeostasis
Prevention of autoinflammation by clearing nucleic acids
The enzyme hydrolyzes DNA specifically under acidic conditions, explaining its effectiveness in the acidic environment of lysosomes where it degrades DNA expelled from erythroid precursor cells and DNA from engulfed apoptotic cells .
DNASE2 antibodies have been validated for multiple applications according to manufacturer data:
| Application | Validated Uses | Typical Dilutions |
|---|---|---|
| Western Blot (WB) | Detecting endogenous DNASE2 | 1:1000-1:8000 |
| Immunoprecipitation (IP) | Isolating DNASE2 complexes | 0.5-4.0 μg for 1.0-3.0 mg total protein |
| Immunohistochemistry (IHC) | Tissue localization studies | 1:1000-1:4000 |
| Immunofluorescence (IF/ICC) | Cellular localization | 1:50-1:500 |
| ELISA | Quantitative detection | Varies by kit |
Multiple cell lines have shown positive results with DNASE2 antibodies, including HEK-293 cells, HeLa cells, LNCaP cells, and MDA-MB-231 cells for Western blot applications . For immunoprecipitation, U-87 MG cells and HeLa cells have been successfully used .
Most commercially available DNASE2 antibodies show reactivity with:
Human
Mouse
Rat
Some antibodies have been specifically tested and validated with human, mouse, and rat samples as noted in product information sheets . Researchers should check specific product information for cross-reactivity when planning experiments involving other species.
To verify specificity of DNASE2 antibodies:
Positive controls: Use cell lines with known DNASE2 expression (HeLa, HEK-293) as positive controls .
Knockdown/knockout validation:
Immunoprecipitation validation: Perform IP followed by Western blot to confirm the antibody pulls down the correct protein.
Blocking peptide: Use the immunizing peptide to block antibody binding and confirm specificity .
Multiple antibodies: Compare results using antibodies targeting different epitopes of DNASE2.
Research by Chan et al. generated specific anti-mouse DNASE2 monoclonal antibodies by immunizing DNASE2-deficient mice with wild-type DNASE2 protein, screening using Ba/F3 cells expressing DNASE2 on their surface .
DNASE2 is detected at varying molecular weights due to proteolytic processing and post-translational modifications:
Calculated molecular weight: 40 kDa (360 amino acids)
Pro-enzyme form: ~40-45 kDa
Processed forms: 30 kDa and 23 kDa forms detected in lysosomes
Research has shown that DNASE2 undergoes proteolytic processing in vivo. Western blot detection using a carboxyl-terminal antibody revealed two predominant forms (30 kDa and 23 kDa) in lysosomes, rather than the expected 45 kDa form . This processing is significantly altered in mice lacking cathepsin L, indicating that this protease is involved in DNASE2 maturation .
The extracellularly secreted DNASE2 is detected as a pro-form that becomes activated under acidic conditions, suggesting that proteolytic processing occurs in lysosomes and is necessary for full enzymatic activity .
For robust DNASE2 antibody experiments, include these controls:
Positive tissue controls:
Negative controls:
Primary antibody omission
Isotype control (rabbit IgG)
DNASE2 knockout/knockdown samples
Blocking peptide competition
Loading controls for Western blot:
Housekeeping proteins (β-actin, GAPDH)
Total protein stain methods
Expression controls:
Functional controls:
DNase activity assay to correlate protein detection with enzymatic function
DNASE2 antibodies are valuable tools for investigating DNA clearance mechanisms:
Colocalization studies: Use IF/ICC with DNASE2 antibodies and DNA dyes to:
Track undegraded DNA in lysosomes
Monitor nuclear DNA export to lysosomes
Study autophagy-mediated DNA delivery to lysosomes
Phagocytosis assays: Use DNASE2 antibodies to:
Track DNASE2-mediated degradation of engulfed apoptotic cells
Study professional phagocytes like macrophages and dendritic cells
Disease models:
Autoimmunity: Examine DNASE2 function in models of autoimmune disease
Inflammation: Study DNASE2's role in preventing activation of cytoplasmic DNA sensors
Erythropoiesis: Investigate DNASE2 in models of erythroid maturation
Research by Eckard et al. showed that DNASE2-deficient mice develop autoantibodies against DNA-associated antigens. Using bifunctional immunoglobulins with DNA binding domains, they demonstrated that DNASE2-deficient B cells fail to respond to DNA-containing complexes, suggesting a role for DNASE2 in properly processing DNA-associated autoantigens .
DNASE2 antibodies enable detailed subcellular localization studies:
Lysosomal localization:
Use DNASE2 antibodies with lysosomal markers (LAMP1/2) to confirm localization
Monitor DNASE2 trafficking to lysosomes under different conditions
Subcellular fractionation:
Autophagy pathway:
Nuclear DNA export:
The study by Lan et al. demonstrated that DNASE2 is essential for clearance of damaged nuclear DNA through an autophagy-dependent mechanism. They observed co-localization of DNA with lysosomes in DNASE2-deficient cells, suggesting that DNASE2 acts in lysosomes to degrade DNA delivered there by autophagy .
Detection of endogenous DNASE2 requires specific approaches:
Enrichment strategies:
IHC optimization:
IF/ICC protocols:
Fixation: 4% paraformaldehyde is typically effective
Permeabilization: Use 0.1% Triton X-100 for accessing intracellular antigens
Co-staining: Combine with lysosomal markers like LAMP1
Activity correlation:
DNASE2 mutations impact both antibody detection and functional studies:
Loss-of-function mutations:
Antibody epitope considerations:
Mutations may affect antibody recognition if they occur within the epitope region
Antibodies targeting different regions may show differential detection of mutant proteins
Functional impact assessment:
DNase activity assays reveal enzyme activity loss in mutant proteins
Cellular accumulation of undegraded DNA can be visualized by DNA dyes
Protein stability effects:
Some mutations may affect protein stability or processing
Western blot may reveal altered molecular weight patterns or reduced protein levels
Research by Rodero et al. demonstrated that biallelic mutations in DNASE2 lead to autoinflammation due to activation of the STING-dependent interferon pathway by undegraded DNA .
DNASE2 antibodies are valuable tools for investigating autoinflammatory mechanisms:
Patient sample analysis:
Compare DNASE2 expression and localization in patient vs. control samples
Assess DNASE2 processing in affected tissues
DNA accumulation studies:
Use DNASE2 antibodies with DNA dyes to visualize DNA accumulation
Track DNA localization in lysosomes and cytosol
Signaling pathway activation:
Study STING pathway activation downstream of DNASE2 deficiency
Monitor type I interferon production and signaling
Therapeutic testing:
Evaluate potential therapies that might compensate for DNASE2 deficiency
Monitor changes in DNA accumulation and inflammatory markers
Rodero et al. identified patients with biallelic DNASE2 mutations who presented with severe neonatal anemia, membranoproliferative glomerulonephritis, liver fibrosis, and arthropathy. They demonstrated that these mutations resulted in loss of DNase II function, leading to activation of the interferon pathway by undegraded DNA .
DNASE2 antibodies can illuminate several aspects of immune function:
Phagocytosis studies:
Track DNASE2-mediated degradation of DNA in phagocytes
Compare wild-type and DNASE2-deficient phagocytes
TLR9 interaction:
Innate immunity:
B cell activation:
The research by Chan et al. demonstrated that DNASE2 digestion of DNA in endolysosomes is required for proper TLR9 sensing, revealing a previously unappreciated role for DNASE2 in innate immune recognition of DNA .
DNASE2 antibodies help visualize multiple cellular consequences of DNASE2 deficiency:
DNA accumulation patterns:
Subcellular DNA localization:
DNASE2 antibodies combined with DNA dyes reveal DNA accumulation in:
Lysosomes
Cytoplasmic compartments
Extra-nuclear spaces
Autophagy pathway visualization:
Co-staining with autophagy markers reveals:
Impaired clearance of damaged nuclear DNA
Defective autophagy-lysosome pathway function
Inflammation activation:
DNASE2 antibodies help track:
DNA sensor activation (STING pathway)
Inflammatory signaling cascade initiation
Lan et al. observed that DNASE2-deficient cells accumulate DNA not only from phagocytosed material but also from damaged nuclear DNA. They demonstrated that this accumulation triggers inflammation via the STING cytosolic DNA-sensing pathway .
Proper storage is critical for maintaining DNASE2 antibody performance:
According to manufacturer guidelines, DNASE2 antibodies are typically supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3. They remain stable for one year after shipment when stored at -20°C .
Researchers may encounter several challenges when working with DNASE2 antibodies:
Multiple band detection:
Low signal intensity:
High background in IF/ICC:
Issue: Non-specific staining
Solution: Optimize blocking (5% BSA or serum), increase washing steps, and validate specificity with knockout controls
Variability between tissue types:
Issue: Different tissues show varying detection patterns
Solution: Optimize protocols for each tissue type; consider tissue-specific processing differences
Cross-reactivity concerns:
Issue: Potential detection of related proteins
Solution: Validate with DNASE2 knockout samples or blocking peptides
Shiokawa and Tanuma demonstrated that partial purification using Con A Sepharose significantly improved detection of endogenous DNASE2 forms by Western blotting, enabling visualization of the distinct 30 kDa and 23 kDa processed forms .
Application-specific optimization strategies for DNASE2 antibodies:
Western Blot Optimization:
Sample preparation: Consider enrichment with Con A Sepharose for endogenous detection
Loading control: β-actin is commonly used
Expected bands: 32-40 kDa for the pro-enzyme; 23-30 kDa for processed forms
Immunohistochemistry Optimization:
Antigen retrieval: TE buffer pH 9.0 or citrate buffer pH 6.0
Visualization system: HRP or AP-based detection systems
Immunofluorescence Optimization:
Fixation: 4% paraformaldehyde (10-15 minutes)
Permeabilization: 0.1-0.5% Triton X-100
Counterstaining: DAPI for nuclei, specific organelle markers as needed
Immunoprecipitation Optimization:
Lysate preparation: Use 1.0-3.0 mg of total protein
Beads: Protein A/G for rabbit polyclonal antibodies
Elution: Use SDS sample buffer for Western blot analysis
For detection of extracellular DNASE2, researchers have successfully used Con A Sepharose followed by immunoprecipitation with anti-FLAG antibody, as described by Shiokawa and Tanuma .